Oral Communications

DAY 2 – Tuesday, May 8


9.45 – 9.57  Cell activation, death and motility of human Th17 cells are finely regulated by specific transcription factors
Elisabetta Volpe (Santa Lucia Foundation, Rome)

9.57 – 10.09 Genomic and functional evaluation of the role of TNFSF14 gene in susceptibility to multiple sclerosis
Miriam Zuccalà (University of Eastern Piedmont, Novara)

10.09 – 10.21 Immune and central nervous system-related miRNA expression profiling in monocytes of Multiple Sclerosis patients
Antonella Amoruso (University of Foggia, Foggia)

10.21 – 10.33 Mapping B cell and monocyte specific pathogenic signatures in relapsing-remitting Multiple Sclerosis: an Interferome-based transcriptomic approach
Martina Severa (Istituto Superiore di Sanità, Rome)

10.33 – 10.45 Dissecting the gene-environment interaction in multiple sclerosis through a “candidate-interactome” approach
Giulia Pellicciari (Sant’Andrea Hospital, Sapienza University, Rome)


12.00 – 12.12 Thymoma-associated myasthenia gravis and neuromyotonia comorbidity: a clinical and serological study
Matteo Gastaldi (IRCCS C Mondino, Pavia)

12.12 – 12.24 Natural Killer/B cells interactions in neurological diseases: role of KIR2DL2 and CD40/CD40L in Herpesivirus infections
Daria Bortolotti (University of Ferrara, Ferrara)

12.24 – 12.36 Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis
Mauro Tognon (University of Ferrara, Ferrara)

12.36 – 12.48 Age-induced immune alterations contribute to the worse outcome of stroke in the elderly
Giorgia Serena Gullotta (San Raffaele Scientific Institute, Milan)

12.48 – 13.00 Specialized pro-resolving mediators as novel therapeutic agents in treating neuroinflammation
Alessandro Leuti (European Center for Brain Research IRCCS Santa Lucia Foundation, Milan)


DAY 3 – Wednesday, May 9


9.45 – 9.57  Gut Flora, MAIT cells and Multiple Sclerosis
Francesca Gargano (Santa Lucia Foundation, Milan)

9.57 – 10.09 Alteration of the human gut microbiome in Clinically Isolated Syndrome
Simona Rolla (University of Turin, Turin)

10.09 – 10.21 Gut microbiota in Myasthenia Gravis and Multiple Sclerosis patients
Elena Rinaldi (Neurological Insitute Carlo Besta, Milan)

10.21 – 10.33 Distinct Transcriptional Profiles Define Conventional T versus Regulatory T cell responses to signal of starvation
Claudio Procaccini (CNR Consiglio Nazionale delle Ricerche)

10.33 – 10.45 The satiety factor oleoylethanolamide affects the gut microbiome and modulates inflammatory cytokine production in intestinal peyer’s patches 
Alessia Costa (University of Florence, Florence)



15.00 – 15.12 Human pluripotent stem cell derived micrglia-like cells
Rosa Bonaccorso (Vita and Salute San Raffaele University, Milan)

15.12 – 15.24 Microglia-derived Extracellular Vesicles regulate the recruitment, proliferation and differentiation of oligodendrocyte precursor cells
Marta Lombardi (ARC Istituto Clinico Humanitas, Milan)

15.24 – 15.36 Loss of optineurin in microglia leads to disbalance in pro- and anti-inflammatory factors regulated by IFN-beta Andrea
Markovinović (Universtiy of Rijeka, Rijeka)

15.36 – 15.48 Microglia proliferation after stroke is CSF-1 dependent
Marco Bacigaluppi (San Raffaele Scientific Institute, Milan)

15.48 – 16.00 Oxidized-Low-Density-Lipoprotein vaccination in EAE mice
Maira Gironi (San Raffaele Hospital, Milan)

16.00 – 16.12 Coenzyme A synthase controls pathogenic features in myelin-specific T cells by linking metabolic reprogramming to alteration of intracellular signaling pathways
Tommaso Carlucci (University of Verona, Verona)

16.12 – 16.24 TrkB in astrocytes supports acute and chronic CNS injury
Emanuela Colombo (San Raffaele Hospital, Milan)

16.24 – 16-36 Trafficking properties of antigen-specific T cells and their ability to drive EAE: Interactions among Mycobacterium-derived products and a polymorphic TLR2
Francesco Ria (Università Cattolica del Sacro Cuore, Rome)


DAY 4 – Thursday, May 10


9.45 – 9.57 Human CD3+CD56+ cells, a novel regulatory subset involved in multiple sclerosis pathogenesis
Sara Bruzzaniti (IEOS-CNR, Naples)

9.57 – 10.09 Possible involvement of the Repressor Element 1-Silencing Transcription factor in the pathological process of experimental autoimmune encephalomyelitis
Valentina Petrosino (University of Genoa, Genoa)

10.09 – 10.21 Interleukin-6 affects clinical course and brain plasticity in Multiple Sclerosis patients
Alessandra Musella (IRCCS San Raffaele, Milan)

10.21 – 10.33 Activation of the hydroxycarboxylic acid receptor-2 by monomethyl fumarate triggers different pathways in different cell types
Nicole Kerlero De Rosbo (University of Genoa, Genoa)

10.33 – 10.45 Central vein sign in patients with Multiple Sclerosis and markers of “better explanation” of the disease
Luca Massacesi (University of Florence, Florence)



12.00 – 12.12 Pro-inflammatory cytokinies alter gabaERGIC sinaptic currents in spinal organotypic slices
Vincenzo Giacco (SISSA, Trieste)

12.12 – 12.24 Interleukin 17 affects hippocampal plasticity and cognition in multiple sclerosis
Andrea Mancini (University of Perugia)

12.24 – 12.36 An optimized isolation protocol identifies two distinct subpopulations of microglia-derived microvesicles
Annamaria Nigro (San Raffaele Scientific Institute)

12.36 – 12.48 Neuroinflammatory stress on cultured spinal networks
Giulia Panattoni (SISSA, Trieste)

12.48 – 13.00 A clarified rat cochlea – brainstem preparation for the visualization of inflammation spread after ototoxic treatment
Paola Perin (University of Pavia, Pavia)